InvestorsHub Logo
Followers 505
Posts 6242
Boards Moderated 0
Alias Born 09/20/2006

Re: Investor100 post# 528

Wednesday, 01/28/2015 10:13:56 PM

Wednesday, January 28, 2015 10:13:56 PM

Post# of 689
Horizon Pharma plc to Host Fourth Quarter 2014 Conference Call and Webcast on February 27, 2015

About Horizon Pharma plc
Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. The Company markets a portfolio of products in arthritis, inflammation and orphan diseases. Horizon's U.S. marketed products are ACTIMMUNE® (interferon gamma-1b), DUEXIS® (ibuprofen/famotidine), PENNSAID® (diclofenac sodium topical solution) 2% w/w, RAYOS® (prednisone) delayed-release tablets and VIMOVO® (naproxen/esomeprazole magnesium). Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com.

Investor 100

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.